Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ensysce Biosciences Inc (ENSC)

Ensysce Biosciences Inc (ENSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ensysce Biosciences Inc 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 USA

www.ensysce.com P: 858-263-4196

Description:

Ensysce Biosciences is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is involved in developing tamper-proof opioids which prevent both drug abuse and overdoses. Ensysce Biosciences, formerly known as Leisure Acquisition Corp., is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 4,007
Enterprise Value, $K 2,887
Shares Outstanding, K 7,329
Annual Sales, $ 2,230 K
Annual Net Income, $ -10,610 K
Last Quarter Sales, $ 520 K
Last Quarter Net Income, $ -3,500 K
EBIT, $ -10,720 K
EBITDA, $ -10,390 K
60-Month Beta 0.77
% of Insider Shareholders 52.70%
% of Institutional Shareholders 5.63%
Float, K 3,467
% Float 47.30%
Short Volume Ratio 0.65

Growth:

1-Year Return -84.33%
3-Year Return -99.98%
5-Year Return -99.98%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 91.12%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.13 on 03/15/24
Latest Earnings Date 05/20/24
Earnings Per Share ttm -5.06
EPS Growth vs. Prev Qtr -29.89%
EPS Growth vs. Prev Year 93.81%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 03/31/23

ENSC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,024.79%
Return-on-Assets % -262.37%
Profit Margin % -475.78%
Debt/Equity 0.00
Price/Sales 1.84
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.21
Interest Coverage -29.37
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar